Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Conditions:   Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   B-Cell Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematologic and Lymphocytic Disorder;   Hematopoietic Cell Transpla ntation Recipient;   Myelodysplastic Syndrome;   Primary Myelofibrosis;   Secondary Myelofibrosis;   T-Cell Non-Hodgkin Lymphoma;   Thrombocytopenia;   Venous Thromboembolism Interventions:   Biological: Platelet Transfusion;   Biological: Platelet Transfusion Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI) Enrolling by invitation - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials